Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. logo
🇨🇳China
Ownership
Public, Subsidiary
Established
2002-01-25
Employees
1K
Market Cap
-
Website
https://www.3s-guojian.com

Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects

First Posted Date
2020-04-29
Last Posted Date
2020-04-29
Lead Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Target Recruit Count
62
Registration Number
NCT04367441
Locations
🇨🇳

Public Health Clinical Center (Shanghai), Jinshan, Shanghai, China

Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis

First Posted Date
2020-04-14
Last Posted Date
2020-04-14
Lead Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Target Recruit Count
640
Registration Number
NCT04345458
Locations
🇨🇳

Chinese PLA General Hospital clinical trial center, Beijing, Beijing, China

The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)

Phase 1
Conditions
Interventions
First Posted Date
2019-11-05
Last Posted Date
2019-11-05
Lead Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Target Recruit Count
50
Registration Number
NCT04151407
Locations
🇨🇳

Shanghai General Hospital, Shanghai, Shanghai, China

🇨🇳

Chinese PLA General Hospital of Central Theater., Wuhan, Hubei, China

🇨🇳

JiangSu Province Hospital, Nanjing, Jiangsu, China

and more 1 locations

Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China

Not Applicable
Conditions
Interventions
First Posted Date
2019-06-26
Last Posted Date
2020-09-09
Lead Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Target Recruit Count
24
Registration Number
NCT03998345
Locations
🇨🇳

Cancer hospital Chinese academy of medical sceience, Beijing, Beijing, China

Pharmacokinetics, Efficacy and Safety of the 304 Injection

First Posted Date
2019-06-10
Last Posted Date
2019-06-10
Lead Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Target Recruit Count
60
Registration Number
NCT03980379
Locations
🇨🇳

The First Affiliated Hospita of Zhengzhou University, Zhengzhou, Henan, China

🇨🇳

The 307 Hospital of People's Liberation Army, Beijing, Beijing, China

🇨🇳

Beijing Luhe Hospital Capital Medical University, Beijing, Beijing, China

and more 7 locations

Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A

Phase 1
Conditions
Interventions
First Posted Date
2019-05-15
Last Posted Date
2020-04-03
Lead Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Target Recruit Count
24
Registration Number
NCT03950297
Locations
🇺🇸

NEXT Oncology Business Office, San Antonio, Texas, United States

A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

First Posted Date
2017-11-29
Last Posted Date
2018-09-17
Lead Sponsor
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Target Recruit Count
21
Registration Number
NCT03356158
Locations
🇨🇳

Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

© Copyright 2024. All Rights Reserved by MedPath